Determining the Relationships of Different Global Disclosure Requirements
This webinar happened on 03 May, 2017
Dont worry if you missed it, we have it recorded for you.
Takeaway From This Webinar:
- Overview of EFPIA Disclosure Code
- Impact of the Transparency Movement—individual company and country cases
- Forms of disclosure/publication
- Disclosure by country—the case of Germany, UK, the Netherlands and USA (Open Payments Data)
This webinar dissects the specific disclosure requirements of pharma transparency efforts in markets within Europe and the USA. Participants are expected to learn from the presenter’s analysis of transparency bodies in Germany, the Netherlands and UK, and debating the pros and cons of each.
Who Should Attend?
Senior and mid-level Transparency, Corporate Compliance and Legal Professionals from the pharmaceutical manufacturing industry in Europe.
Dr. Klaus Geldsetzer
Chief Compliance Officer EMEA
Co-Speaker & Moderator
Digital Marketing Manager